Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Bridgebio Pharma Inc (BBIO)

Bridgebio Pharma Inc (BBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Is Pfizer Stock a Yield Trap? Motley Fool - Thu Jul 3, 3:21AM CDT

BBIO : 46.34 (+0.78%)
NVS : 123.75 (+0.66%)
PFE : 25.75 (+0.74%)
BMY : 48.49 (+1.74%)
BridgeBio Raises $300 Million Through Partial Capped Monetization of BEYONTTRA® European Royalty GlobeNewswire - Mon Jun 30, 6:30AM CDT

OWL : 19.61 (+0.87%)
BBIO : 46.34 (+0.78%)
BridgeBio to Host Limb-girdle Muscular Dystrophy Type 2I/R9 Investor Webinar on Friday, July 11th at 8:00 am ET GlobeNewswire - Thu Jun 26, 6:30AM CDT

BBIO : 46.34 (+0.78%)
Better High-Yield Dividend Stock to Buy Now: Pfizer vs. Prologis Motley Fool - Thu Jun 5, 2:34AM CDT

MCO : 506.02 (+0.76%)
PLD : 108.41 (+1.90%)
SPGI : 530.12 (+0.26%)
BBIO : 46.34 (+0.78%)
FDX : 238.75 (+0.95%)
HD : 373.74 (+0.73%)
PFE : 25.75 (+0.74%)
AMZN : 222.12 (-0.19%)
BMY : 48.49 (+1.74%)
BridgeBio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025 GlobeNewswire - Mon Jun 2, 6:30AM CDT

BBIO : 46.34 (+0.78%)
Acoramidis Reduced Incidence of Atrial Fibrillation Events in Patients with ATTR-CM GlobeNewswire - Tue May 20, 6:30AM CDT

BBIO : 46.34 (+0.78%)
Early and Sustained Increase in Serum TTR Levels by Acoramidis Independently Predicted Improved Survival in the ATTRibute-CM Study GlobeNewswire - Mon May 19, 11:33AM CDT

BBIO : 46.34 (+0.78%)
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Wed May 14, 3:01PM CDT

BBIO : 46.34 (+0.78%)
First Participant Dosed with Acoramidis in ACT-EARLY, the First Ever ATTR Primary Prevention Study GlobeNewswire - Tue May 13, 6:30AM CDT

BBIO : 46.34 (+0.78%)
BridgeBio to Present Clinical Outcomes, Quality of Life Measures and Incidence of Atrial Fibrillation Events in Patients with ATTR-CM from the ATTRibute-CM Study at the Annual Congress of the Heart Failure Association of the ESC GlobeNewswire - Mon May 12, 6:30AM CDT

BBIO : 46.34 (+0.78%)

Barchart Exclusives

Intel Is Kicking Off a Major Layoffs Push. What Do the Job Cuts Mean for INTC Stock? Barchart - 18 minutes ago
Intel’s sweeping layoffs highlight a dramatic push to cut costs and streamline operations as it battles to reclaim lost market share. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot